ATS Medical Announces Initial Clinical Results Of Stand Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, announced initial clinical results of stand-alone ablation procedures and an overall expansion into the stand-alone market, using the ATS CryoMaze(TM) product line.
More: continued here
Filed under: Cardiovascular on February 26th, 2008